(Q35088019)

English

The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5

object named as

Sam S Chang

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

David J Grossklaus

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Joseph A Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Scott B Shappell

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Christopher S Coffey

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Michael S Cookson

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

195-198

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ratio of free-to-total prostate specific antigen correlates with tumor volume in patients with increased prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The free-to-total serum prostatic specific antigen ratio as a predictor of the pathological features of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of percent free prostate specific antigen for staging clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Free, complexed and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of three molecular forms of prostate-specific antigen ratios in patients with prostate adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1078-1439(02)00190-4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35088019&oldid=1990497048"